Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
25
27
28
29
1
3
5
6
7
8
11
13
15
17
18
19
20
21
22
24
25
27
28
29
31
1
2
3
4
5
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Beauty Care Asia Pacific Summit 2020 (BCAP)
2020-03-02 - 2020-03-04    
All Day
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-03-04 - 2020-03-05    
All Day
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Global Drug Delivery And Formulation Summit 2020
2020-03-09 - 2020-03-11    
All Day
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Inborn Errors Of Metabolism Drug Development Summit 2020
2020-03-10 - 2020-03-12    
All Day
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Texting And E-Mail With Patients: Patient Requests And Complying With HIPAA
2020-03-12    
All Day
Overview:  This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
14 Mar
2020-03-14 - 2020-03-21    
All Day
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
International Conference On Healthcare And Clinical Gerontology ICHCG
2020-03-14 - 2020-03-15    
All Day
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
World Congress And Expo On Cell And Stem Cell Research
2020-03-16 - 2020-03-17    
All Day
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
25th International Conference on  Diabetes, Endocrinology and Healthcare
2020-03-23 - 2020-03-24    
All Day
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ISN World Congress of Nephrology 2020
2020-03-26 - 2020-03-29    
All Day
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
30 Mar
2020-03-30 - 2020-03-31    
All Day
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics In Internal Medicine 2020
2020-04-02 - 2020-04-04    
All Day
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today.   This course will help you discuss options [...]
2020 Summit On National & Global Cancer Health Disparities
2020-04-03 - 2020-04-04    
All Day
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Events on 2020-02-26
Events on 2020-03-02
Events on 2020-03-09
Events on 2020-03-10
Events on 2020-03-16
Events on 2020-03-26
Events on 2020-03-30
Events on 2020-04-02
Events on 2020-04-03
Articles

It’s 2017. Do you know where your interoperability is?

With January barely behind us and new occupants in the White House, perhaps it’s a good time to set aside what might change for a moment and focus on what must. Interoperability is a more urgent concern in 2017 due to goals established last year by the Office of the National Coordinator (ONCHIT) and the passage of the 21st Century Cures Act, which legally requires healthcare IT interoperability by the end of the current calendar year.

The Interoperability Standards Advisory for 2017, released by ONCHIT in December, is an effort to facilitate interoperability by releasing “essential standards and implementation specifications” determined in dialogue with public and private sector partners. These partners include healthcare IT vendors with products installed in 90 percent of U.S. hospitals that have also made a public commitment to the ONCHIT-created Interoperability Pledge and its essential elements:

  1. Use standardized APIs.
  2. Make it easier for patients to access data.
  3. Don’t block information.

Even if the pledge itself promises little in the way of holding signees to their promises, the Cures Act will likely prove thornier. As detailed in the legislation, technology certification will require vendors to demonstrate that they are not blocking information or in any way inhibiting data transfer. They must also utilize application programming interfaces (APIs) or a similar data transfer enabling technology.

But while 21st Century Cures may be the match that lights the interoperability pilot, it won’t be the source of heat and energy. If interoperability is achieved this year, it will be because significant technological and policy goals have been identified and realized.

So where do we stand on interoperability in early 2017?

  • Almost all hospitals now have a certified EHR. No, this does not represent a conclusive accomplishment. Rather, virtually universal adoption of EHRs gives us a moment of pause as we look to what still needs to be done. We have the necessary platform, and now we need to keep improving to exchange data amongst entities in a way that makes clinicians more satisfied.
  • Work on an interoperability standard is progressing and showing promise. The Fast Healthcare Interoperability Resources (FHIR) standard that Health Level 7 (HL7) has been working on is maturing; the organization expects a normative version to be released this year. That’s good, given the Cures Act mandate.
  • The shift to value-based care is happening and will continue. According to a recent KPMG survey, half of health systems are now reimbursed in part for value-based care hinging on cost and quality factors. A full quarter of survey respondents said they would be engaging in value-based reimbursement plans in the next three years. Only 7 percent said they would not. The train is in motion and it requires comprehensive healthcare IT that is fully enabled to exchange information as effectively as possible.

Of course, no one is arguing that now is the time for clinking champagne flutes and excessive back-slapping. Industry surveys and anecdotal data tell us a story of unsatisfied clinicians who still lack full patient data and are hindered clinically as a result.

What must still be accomplished in 2017 to move closer to fulfilling visions of a comprehensive healthcare IT system nationwide?

  • Continue pursuit of a standard. Right now FHIR is the front-runner for default healthcare IT standard. The smart money might bet on FHIR because it has a development timeline advantage, but there are no guarantees. Normative status for FHIR means vendors could potentially include it in products in time to meet Cures Act requirements.
  • Create application programming interface (API) initiatives. Earlier this year, Chilmark Research released a report on APIs in healthcare with recommendations for each industry participant.
    • Health care organizations should initiate API programs, urge EHR vendors to develop APIs, start API governance discussions and focus on user interface issues.
    • HIT vendors must start programs with FHIR and APIs, and re-evaluate interfaces from a product rather than services perspective
    • Payers need API programs, too, starting with paid claims data. They should also cultivate relationships with independent developers.
    • Data integrators should understand how to support FHIR and utilize a value-based monetization model as opposed to an access-based model.
    • Device manufacturers will look to partnering with EHR vendors and integrators, and should also embrace a value-based monetization mode.
  • Revamp healthcare further. It’s not just value-based payment models that are changing the provision of healthcare. As John Glaser writes in Hospitals and Health Networks, collective industry actions point toward establishing healthcare IT solutions that include but do not culminate with APIs and FHIR. The number of accountable care organizations, currently approaching 800, continues to grow as technology enables both care coordination and multi-payer risk.

The larger message and broader vision in Glaser’s interoperability article is one healthcare would do well to embrace. Healthcare is not simply engaged in technical interoperability; the industry is also breaking out of an approach to care that walls off bits of patient data in the separate files of different providers, that primarily pays for procedures and solutions after the patient has fallen ill, and that too often proscribes incomplete solutions for complex, comorbid health concerns.

Healthcare is moving toward an industry-wide interoperability that can’t fully emerge until the technology to enable it has matured. There’s a better-than-average chance 2017 is the year we start to see real benefit.

D’Arcy Gue is Director of Industry Relations for Medsphere Systems Corporation.